Walleye Capital
PRCT icon

Walleye Capital’s Procept Biorobotics PRCT Stock Holding History

Walleye Capital’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,600
Closed -$302K – 4851
2025
Q4 		$302K Buy
9,600
+5,000
+109% +$166K ﹤0.01% 3314
2025
Q3 		$164K Sell
4,600
-700
-13% -$32K ﹤0.01% 3442
2025
Q2 		$305K Buy
5,300
+2,000
+61% +$113K ﹤0.01% 3042
2025
Q1 		$192K Buy
3,300
+2,700
+450% +$184K ﹤0.01% 3285
2024
Q4 		$48.3K Buy
600
+400
+200% +$34.2K ﹤0.01% 4366
2024
Q3 		$16K Hold
200
– – ﹤0.01% 4856
2024
Q2 		$12.2K Buy
+200
New +$11.9K ﹤0.01% 5196

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Walleye Capital's PRCT Position: Q4 2025 in Review

Walleye Capital sold out of Procept Biorobotics (PRCT) in Q4 2025, closing a stake of 1,566 shares — an estimated $51.9K sold.

Walleye Capital first reported a position in PRCT in Q4 2023 and held it in 6 quarters. The position peaked at $2.77M in Q2 2024. 263 funds tracked by Wall St. Rank hold PRCT as of Q4 2025.

  • Walleye Capital reported no remaining Procept Biorobotics position as of Q4 2025 after selling out during the quarter.
  • Walleye Capital sold 1,566 Procept Biorobotics shares in Q4 2025, an estimated $51.9K.
  • Walleye Capital first reported a position in Procept Biorobotics in Q4 2023 and held it in 6 quarters.
  • Walleye Capital's Procept Biorobotics position peaked at $2.77M in Q2 2024.
  • 263 funds tracked by Wall St. Rank held Procept Biorobotics as of Q4 2025.

Based on Walleye Capital's 13F filing for Q4 2025, filed 13 Feb 2026.